Researchers examined 509 consecutive patients with acute leukemia admitted to a hospital between 2006 and 2017.
They found:
• Incidence of C. diff was 2.2 per 1,000 inpatient days during induction therapy.
• C. diff was rare after hospital discharge.
• C. diff was highest in patients with acute myelogenous leukemia.
• A hospitalization shortly before admission and administration of a higher number of antibiotics increased the risk for C. diff.
• No single class of antibiotics conveyed an increased risk.
The researchers also found all cases were successfully treated, and C. diff was not associated with an increase in length of stay, costs or mortality.
More articles on healthcare quality:
AHA weighs in on proposed star ratings changes: 4 things to know
Stop calling physicians ‘second victim’ of medical errors, patient advocates say
26 states still report high flu activity: 6 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.